We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+14.75%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.48B
AUM Growth
+$231M
Cap. Flow
-$87.3M
Cap. Flow %
-2.51%
Top 10 Hldgs %
17.4%
Holding
433
New
64
Increased
81
Reduced
104
Closed
64

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$29M
2
CNC icon
Centene
CNC
+$17.6M
3
KBR icon
KBR
KBR
+$16.5M
4
CDW icon
CDW
CDW
+$16.2M
5
IQV icon
IQVIA
IQV
+$16.1M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$27M
2
PVH icon
PVH
PVH
+$18.7M
3
TPR icon
Tapestry
TPR
+$18.2M
4
IART icon
Integra LifeSciences
IART
+$18.1M
5
MTZ icon
MasTec
MTZ
+$17.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.56%
2 Technology 18%
3 Consumer Discretionary 12.44%
4 Industrials 12.24%
5 Energy 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNMD icon
126
CONMED
CNMD
$1.41B
$9.59M 0.28%
121,045
-1,880
-2% -$145K
P
127
DELISTED
Pandora Media Inc
P
$9.42M 0.27%
990,200
+342,580
+53% +$2.89M
MMP
128
DELISTED
Magellan Midstream Partners, L.P.
MMP
$9.15M 0.26%
135,182
+30,270
+29% +$2.1M
EFOR
129
Everforth Inc
EFOR
$1.39B
$9.15M 0.26%
+115,895
New +$10M
AVTA
130
DELISTED
Avantax, Inc. Common Stock
AVTA
$9.06M 0.26%
225,145
+33,800
+18% +$1.23M
TRHC
131
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$9.04M 0.26%
111,287
-69,010
-38% -$5.05M
AORT icon
132
Artivion
AORT
$1.24B
$9.03M 0.26%
+256,514
New +$8.27M
CARB
133
DELISTED
Carbonite Inc
CARB
$8.52M 0.24%
+239,041
New +$9.19M
MPLX icon
134
MPLX
MPLX
$59.2B
$8.46M 0.24%
243,998
MASI
135
DELISTED
Masimo
MASI
$8.41M 0.24%
+67,555
New +$7.49M
STAA icon
136
STAAR Surgical
STAA
$1.13B
$8.34M 0.24%
+173,800
New +$7.12M
GILD icon
137
Gilead Sciences
GILD
$181B
$8.15M 0.23%
105,508
-1,000
-0.9% -$75.5K
SMPL icon
138
Simply Good Foods
SMPL
$870M
$8.08M 0.23%
+415,569
New +$7.23M
PTCT icon
139
PTC Therapeutics
PTCT
$5.48B
$7.99M 0.23%
+169,920
New +$7.03M
FLIR
140
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$7.95M 0.23%
129,400
-1,275
-1% -$75.1K
FISV
141
Fiserv Inc
FISV
$26.6B
$7.91M 0.23%
95,980
+3,240
+3% +$254K
BMI icon
142
Badger Meter
BMI
$3.66B
$7.9M 0.23%
+149,237
New +$7.76M
CURO
143
DELISTED
CURO Group Holdings Corp.
CURO
$7.88M 0.23%
260,739
-22,225
-8% -$638K
UPLD icon
144
Upland Software
UPLD
$11.1M
$7.88M 0.23%
24,373
-378
-2% -$131K
NVRI icon
145
Enviri
NVRI
$606M
$7.86M 0.23%
275,345
-4,270
-2% -$111K
GDDY icon
146
GoDaddy
GDDY
$13B
$7.84M 0.23%
94,080
-7,980
-8% -$623K
MRO
147
DELISTED
Marathon Oil Corporation
MRO
$7.62M 0.22%
327,440
COP icon
148
ConocoPhillips
COP
$170B
$7.62M 0.22%
98,460
HES
149
DELISTED
Hess
HES
$7.61M 0.22%
106,240
+22,040
+26% +$1.45M
TTD icon
150
Trade Desk
TTD
$7.05B
$7.56M 0.22%
+500,900
New +$5.94M

Similar funds

Castleark Management's Q3 2018 Portfolio in Review

As of Q3 2018, Castleark Management held 433 positions worth $3.48B, up 7.1% from $3.25B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Castleark Management's Q3 2018 filing shows 64 new, 81 increased, 104 reduced and 64 closed positions. Its largest new stake was Eli Lilly: 289,654 shares worth $31.1M. The largest sale was Charles Schwab, an estimated $27M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Castleark Management's largest Q3 2018 buy was Eli Lilly: 289,654 shares worth $31.1M.
  • Castleark Management added most to CDW in Q3 2018, an estimated $16.2M increase.
  • Castleark Management's biggest Q3 2018 reduction was Charles Schwab, cutting an estimated $27M.
  • Castleark Management fully exited Tapestry in Q3 2018, selling an estimated $18.2M.
  • Castleark Management's ten largest holdings make up 17% of its $3.48B portfolio in Q3 2018.
  • Castleark Management opened 64 new positions and closed 64 in Q3 2018.
  • Castleark Management's portfolio value rose 7.1% quarter-over-quarter to $3.48B.

Based on Castleark Management's 13F filing for Q3 2018, filed 15 Nov 2018.